Andrew J. Armanino is of Better Therapeutics, Inc.. Currently has a direct ownership of 17,084 shares of BTTX, which is worth approximately $170. The most recent transaction as insider was on Dec 18, 2023, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K
0% 3M change
28.12% 12M change
Total Value Held $170

Andrew J. Armanino Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2023
BUY
Grant, award, or other acquisition
-
3,750 Added 18.0%
17,084 Common Stock
Oct 28 2021
BUY
Grant, award, or other acquisition
-
13,334 Added 50.0%
13,334 Common Stock

Also insider at

CALB
California BanCorp Financial Services
AJA

Andrew J. Armanino

Oakland, CA

Track Institutional and Insider Activities on BTTX

Follow Better Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTTX shares.

Notify only if

Insider Trading

Get notified when an Better Therapeutics, Inc. insider buys or sells BTTX shares.

Notify only if

News

Receive news related to Better Therapeutics, Inc.

Track Activities on BTTX